Carvykti genetically modified autologous T cells for infusion Images
Generic Name: ciltacabtagene autoleucel
This medication has been identified as Carvykti genetically modified autologous T cells for infusion and is used for Multiple Myeloma. It belongs to the drug class miscellaneous antineoplastics and is not a controlled substance.
Images of medication
Carvykti
- Generic Name
- ciltacabtagene autoleucel
- Strength
- genetically modified autologous T cells for infusion
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Biotech, Inc.
- National Drug Code (NDC)
- 57894-0111
See also:
More about Carvykti (ciltacabtagene autoleucel)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.